Targeting delivery of miR-146a via IMTP modified milk exosomes exerted cardioprotective effects by inhibiting NF-κB signaling pathway after myocardial ischemia …
W Meng, J Zhu, Y Wang, C Shao, X Li, P Lu… - Journal of …, 2024 - Springer
Reperfusion therapy is critical for saving heart muscle after myocardial infarction, but the
process of restoring blood flow can itself exacerbate injury to the myocardium. This …
process of restoring blood flow can itself exacerbate injury to the myocardium. This …
A comprehensive review of challenges and advances in exosome-based drug delivery systems
Exosomes or so-called natural nanoparticles have recently shown enormous potential for
targeted drug delivery systems. Several studies have reported that exosomes as advanced …
targeted drug delivery systems. Several studies have reported that exosomes as advanced …
[HTML][HTML] Milk-Derived Extracellular Vesicles: A Novel Perspective on Comparative Therapeutics and Targeted Nanocarrier Application
Milk-derived extracellular vesicles (mEVs) are emerging as promising therapeutic
candidates due to their unique properties and versatile functions. These vesicles play a …
candidates due to their unique properties and versatile functions. These vesicles play a …
Oral Delivery of Photoresponsive Milk-Derived Exosomes for the Local Therapy of Glioblastoma
J Choi, H Jang, D Park, B Park, Y Jang, S Lee… - ACS Materials …, 2024 - ACS Publications
Most orally administered drugs struggle to reach intracerebral regions due to the intestinal
epithelial barrier (IEB) and blood–brain barrier (BBB). In this study, we investigate the …
epithelial barrier (IEB) and blood–brain barrier (BBB). In this study, we investigate the …
[HTML][HTML] Milk-derived extracellular vesicles enable gut-to-tumor oral delivery of tumor-activated doxorubicin prodrugs
Rationale: Oral chemotherapy has been emerging as a hopeful therapeutic regimen for the
treatment of various cancers because of its high safety and convenience, lower costs, and …
treatment of various cancers because of its high safety and convenience, lower costs, and …
Exosomal Bupivacaine: Integrating Nerve Barrier Penetration Capability and Sustained Drug Release for Enhanced Potency in Peripheral Nerve Block and Reduced …
Y Cai, Q Li, U Wesselmann… - Advanced Functional …, 2024 - Wiley Online Library
Peripherally injected local anesthetics exhibit limited ability to penetrate peripheral nerve
barriers, which limits their effectiveness in peripheral nerve block and increases the risk of …
barriers, which limits their effectiveness in peripheral nerve block and increases the risk of …
Alendronate-functionalized polymeric micelles target icaritin to bone for mitigating osteoporosis in a rat model
X Sun, Y Lin, X Zhong, C Fan, Z Liu, X Chen… - Journal of Controlled …, 2024 - Elsevier
Formulating drugs into nanoparticles that target sites of disease can lead to strong
therapeutic effects with lower doses of drugs and lower rates of off-target adverse effects …
therapeutic effects with lower doses of drugs and lower rates of off-target adverse effects …
[HTML][HTML] Peptide-Conjugated Vascular Endothelial Extracellular Vesicles Encapsulating Vinorelbine for Lung Cancer Targeted Therapeutics
Lung cancer is one of the major cancer types and poses challenges in its treatment,
including lack of specificity and harm to healthy cells. Nanoparticle-based drug delivery …
including lack of specificity and harm to healthy cells. Nanoparticle-based drug delivery …
Application of fluorocarbon nanoparticles of 131I-fulvestrant as a targeted radiation drug for endocrine therapy on human breast cancer
L Zhi, C Cheng, L Jing, P Zhi-Ping, Y Lu, T Yan… - Journal of …, 2024 - Springer
Background Breast cancer is the most prevalent malignant tumor among women, with
hormone receptor-positive cases constituting 70%. Fulvestrant, an antagonist for these …
hormone receptor-positive cases constituting 70%. Fulvestrant, an antagonist for these …
A strategy for oral delivery of FGF21 for mitigating inflammation and multi-organ damage in sepsis
X Li, D Yu, X Chen, Z Huang, Y Zhao - International Journal of …, 2024 - Elsevier
Abstract Fibroblast growth factor 21 (FGF21) shows great therapeutic potential in metabolic,
neurodegenerative and inflammatory diseases. However, current FGF21 administration …
neurodegenerative and inflammatory diseases. However, current FGF21 administration …